Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials.
Iranian Journal of Psychiatry July 1, 2022 Ahmad Shamabadi, Ali Ahmadzade, Ali Aqamolaei et al.
Objective: Available treatments of depression have limited efficacy and unsatisfactory remission rates. This study aims to review randomized controlled trials (RCTs) investigating effects of glutamate receptor modulators in treating patients with resistant depression. Method : The study protocol was registered in PROSPERO (CRD42021225516). Scopus, ISI Web of Science, Embase, Cochrane Library,...
DOI: 10.18502/ijps.v17i3.9733 (opens in new tab)
Full text (opens in new tab)
Depressive disorder
Behavioral symptoms
Glutamate receptor
Glutamates
+3